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Morphological and functional evaluation of 
an animal model for the retinal degeneration 
induced by N-methyl-N-nitrosourea
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Department of Anatomy, Catholic Institute for Advanced Biomaterials, Th   e Catholic University of Korea College of Medicine, Seoul, Korea
Abstract: Th   e retinal degeneration (RD) is a general cause of blindness. To study its pathophysiology and evaluate the eff  ects 
of new therapeutic agents before clinical trials, it is essential to establish reliable and stable animal models. Th   is study evaluated 
a RD animal model in which blindness was induced by N-methyl-N-nitrosourea (MNU), a potent retinotoxin leading to 
apoptosis of photoreceptors. MNU was applied to the Sprague-Dawley rats by a single intraperitoneal injection in diff  erent 
doses (40, 50, and 60 mg/kg). Th   e retinal functions were examined at 1 week aft  er MNU injection by electroretinogram (ERG). 
Afterwards, each retina was examined by hematoxylin and eosin stain and immunohistochemistry with anti-glial fibrillary 
acidic protein antibody. Upon MNU injection of 40, 50 and 60 mg/kg, the ERG amplitude of a-waves showed significant 
reductions of 7, 26, and 44%, respectively, when compared to that of normal a-waves. Th   e b-wave amplitudes were about 89, 65, 
and 58% of normal b-waves in the response to scotopic light stimulus. At 1 week, 2 weeks, and 4 weeks aft  er MNU injection (50 
mg/kg), all scotopic ERG components decreased progressively. In addition, degeneration of retinal neurons was observed in a 
time- and dose-dependent manner aft  er MNU injection. Taken together, functional reduction following RD induced by MNU 
correlates with morphological changes. Th   us, this RD rat model may be a useful model to study its pathophysiology and to 
evaluate the eff  ects of new therapeutic agents before clinical trials. 
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affects the central vision, leading to complete blindness [2, 
3]. In order to approach available clinical treatments for RD, 
studying its pathophysiology and evaluating the eff  ects of new 
therapeutic agents are essential. However, an important issue 
in this fi  eld is the need for reliable and stable animal model 
for RD research. 
To date, there have been many hereditary animal models 
for RDs [2, 4-6]. In addition to hereditary animal models, 
there are various chemically induced RD models [7] which 
are easier to produce and in which it is easier to modulate 
degrees of change. One of the chemicals, N-methyl-N-
nitrosourea (MNU), is a potent retinotoxin which leads to 
apoptotic cell death of photoreceptor cells [8-15]. Although 
several reports have shown that MNU was very effective 
Introduction
Retinal degeneration (RD) is a general cause of blindness. 
It is a clinically and genetically highly heterogeneous disorder 
affecting many people the world wide [1]. This hereditary 
disease is characterized by the progressive degeneration of 
photoreceptor cells in the retina. It fi  rst infl  uences rods and 
later results in the loss of cones. Eventually, cone degeneration Characterization of RD model induced by MNU
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chemical tool to induce RD in animal models, there are very 
few studies to examine morphological changes and cor-
relation with functional responses of RD induced by MNU 
[13, 16]. Thus, this evaluated a rat model in which RD was 
induced by MNU. We examined morphological changes of 
the retina induced by MNU and evaluated retinal function 
by means of electroretinogram (ERG) according to changes 
in MNU dose. We determined the appropriate dosage of 
MNU for the study of the RD. In addition, we examined 
morphological and functional changes in the degenerating 
retina induced by MNU in the animal model over time. Our 
results suggest that this RD rat model may be a useful model 
to study its pathophysiology and to evaluate the eff  ects of new 
therapeutic agents before clinical trials.
Materials and Methods
Animals
One hundred and seven 10-week-old male albino Sprague-
Dawley (SD) rats were used. All animals were treated accor-
ding to the regulations of the Catholic Ethics Committee of 
the Catholic University of Korea, Seoul, which conform to 
the National Institute of Health (NIH) guidelines for the Care 
and Use of Laboratory Animals (NIH Publications No. 80-23) 
revised 1996.
RD model
Fift  y four SD rats received a single intraperitoneal injection 
of 1% MNU in freshly prepared saline (40, 50 and 60 mg/kg; 
Sigma-Aldrich, St. Louis, MO, USA). One week after MNU 
treatment, rats were sacrificed with 8% chloral hydrate (0.5 
ml/kg) aft  er ERG for visual function tests. Th   irty two SD rats 
injected with 50 mg/kg MNU were also sacrifi  ced 2 weeks and 
4 weeks aft  er MNU treatment. Twenty one control animals (12 
for dose-dependent eff  ects of MNU and 9 for time-dependent 
eff  ects of MNU) were treated with normal saline.
ERG
All rats were dark adapted for 1 hour before ERG ex-
periments and were prepared for recording under dim red 
light (λ>600 nm). Anesthesia was initially induced with an 
intraperitoneal injection of 8% chloral hydrate (0.5 ml/kg). 
Supplemental anesthesia was provided at approximately 
1 hour intervals (8% chloral hydrate 0.2 ml/kg). Animals 
were lightly secured to a stage to ensure a stable position 
for recording the ERG. Th   e top of the stage was fi  xed to the 
position where the animal eye faced the flash light at a 20-
cm distance. Depth of anesthesia was sensitively monitored 
online by inspection of the ERG signal baseline. Th  e  cornea 
was protected with hydroxypropyl methylcellulose gel. A gold 
ring contact electrode was placed on the cornea. A reference 
electrode and a ground electrode were placed subcutaneously 
in the ear and in the tail, respectively. Stimuli were brief 
white fl  ashes (xenon arc discharge) delivered via a Ganzfeld 
integrating sphere (Model UTAS-3000, LKC Technologies, 
Gaithersburg, MD, USA). Stimulus intensities were measured 
using a calibrated photometer with a scotopic luminosity fi  lter 
in place. Because the rat retina is particularly rod-dominant, 
we fi  xed all fl  ash stimuli at scotopic intensities, which better 
reflects the retinal function in this animal. Scotopic ERGs 
obtained for all intensities above 0.9 log (cd s) m
−2 were 
recorded as single fl  ash responses [16, 17]. Each record was an 
average of 6 responses obtained with a 2 second interstimulus 
interval. Signals were recorded with band-pass filters of 1-3 
Hz. The amplitude of the a-wave was measured from the 
baseline to a-wave trough, and b-wave was measured from 
the maximum a-wave trough to the maximum b-wave peak. 
Statistics
Statistical analysis was conducted by ANOVA and Student’s 
t-test to compare ERG differences between control and 
MNU-treated groups. Data are represented as mean±standard 
deviation. The differences were considered statistically 
signifi  cant at P<0.05.
Tissue preservation
The anterior segments of the eyeball were removed. 
Eyecups were fixed by immersion in 4% paraformaldehyde 
in 0.1 M phosphate buffer (PB; pH 7.4) for 3 hours. They 
were rinsed in PB, dehydrated in a graded series of ethanol 
and embedded in wax (polyethylene glycol 400 disterate, 
Polysciences, Warrington, PA, USA). Some 5-μm vertical 
sections of the eyecup were made, dewaxed and rinsed in PB. 
Th   ey were stained with hematoxylin and eosin (H&E).
Immunohistochemistry
Five micrometer vertical sections were used. They were 
incubated in 10% normal donkey serum   in PB for 1 hour at 
room temperature, to block any nonspecific binding sites. 
Th   ey were then incubated with a monoclonal antibody against 
glial fibrillary acidic protein (GFAP; 1 : 1,000, Chemicon, Anat Cell Biol 2011;44:314-323 Eojin Jeong, et al 316
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Temecula, CA, USA) in PB for 1 day at 4
oC. Th   e sections were 
washed in PB for 30 minutes (3×10 minutes) and incubated in 
the presence of Cy3-conjugated donkey anti-mouse IgG (1 : 
1000, Jackson ImmunoResearch, West Grove, PA, USA) for 2 
hours. Aft  er thoroughly washing with PB, the wax embedded 
tissues were mounted with Kaiser’s glycerol gelatin.
Results
Dose-dependent RD induced by MNU injection
Functional assessment by ERG: ERG recordings were ta-
ken to evaluate retinal function of a RD model induced with 
MNU according to changes in MNU dosage. All animals 
treated with MNU showed reductions in both a- and b-wave 
amplitudes 1 week after MNU injection (Fig. 1). When 40 
mg/kg MNU were applied, both ERG responses were reduced 
compared to normal (a-wave, 20.6±3.0 μV vs. 22.1±2.7 μV; 
b-wave, 55.9±4.4 μV vs. 62.8±7.8 μV), but differences were 
statistically insignificant (P>0.05). However, when 50 and 
60 mg/kg MNU were applied, both ERG responses were 
signifi  cantly reduced by 26% and 44% in a-wave and 35% and 
42% in b-wave (P<0.05), respectively, compared to control 
rats (a-wave, 16.3±2.0 μV and 12.4±1.6 μV vs. 22.1±2.7 μV; 
b-wave, 40.9±4.3 μV and 36.2±8.2 μV vs. 62±7.8 μV). Fig. 1C 
shows representative waveforms of ERG responses in control 
and MNU-treated eyes with diff  erent doses. 
Histological aspect by H&E staining: Histopathological 
changes were evaluated in H&E sta  ined retinal vertical 
sections of the control and MNU-trea  ted rats 1 week after 
injection (Fig. 2). Th   e layer number of photoreceptors in the 
outer nuclear layer (ONL) slightly decreased in 40 mg/kg 
MNU-treated rat retinas (Fig. 2B) compared to control rats 
(14-17 layers vs. 12-14 layers). In addition, the arrangement 
of photoreceptors in the ONL was slightly distorted and 
the retina appeared to be edematous, especially the inner 
plexiform layer (IPL) (Fig. 2B). In 50 mg/kg MNU-treated rat 
retinas (Fig. 2C), 10-12 layers of photoreceptors remained, 
Fig. 1. Electroretinogram (ERG) 
recordings taken from eyes of the rats 
1 wk after N-methyl-N-nitrosourea 
(MNU) injection in diff  erent dosages. 
(A, B) Both a- and b-wave amplitudes 
were reduced by 40 mg/kg to 60 mg/kg 
MNU injections in a dose-dependent 
manner. The results are presented as a 
normalized mean±SEM. *P<0.05 vs. 
control. (C) Representative waveforms 
of ERG responses obtained from the 
control eye and MNU-treated eye with 
diff  erent concentrations.Characterization of RD model induced by MNU
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the edematous appearance in the retina continued, and the 
distortion of the inner nuclear layer (INL) was apparent. In 
60 mg/kg MNU-treated rat retinas, numerous photoreceptors 
and bipolar and amacrine cells were degenerated and thus, 
thicknesses of the OPL and the IPL were markedly decreased 
(Fig. 2D). Taken together, our functional and histological 
findings suggest that degenerative changes in the retina 
treated with MNU are dose-dependent. 
Retinal injury evaluation by immunohistochemistry 
with anti-GFAP: By immunohistochemistry with anti-
GFAP, a reliable mar  ker for profiling neurotoxicity [18, 
19], we evaluated the degree of retinal injury according to 
the MNU injection in different doses. In control retinas, 
GFAP was expressed within end feet portion of Müller 
cells and astrocytes located in the ganglion cell layer (GCL) 
(Fig. 3A). Similar to the finding in control retinas, GFAP 
immunoreactivity was found mainly in the GCL, but GFAP-
immunoreactive profiles appeared to become thicker in 40 
mg/kg MNU-treated retinas (Fig. 3B). The expression of 
GFAP increased more in 50 mg/kg MNU-treated retinas than 
in 40 mg/kg MNU-treated retinas and thus, some labeled 
radial processes of Müller cells running in the IPL were 
observed (Fig. 3C). In 60 mg/kg MNU-treated retinas, some 
GFAP-immunoreactive Müller cell processes extended to 
the distal region of the retina passing through the INL (Fig. 
3D). Th   ese results demonstrate that RD in the rat model with 
MNU injection is dose-dependent.
Time-dependent RD induced by MNU injection
Functional assessment by ERG: The initial part of our 
study showed dose-dependent RD eff  ects of MNU. Next, we 
wanted to know whether RD by MNU treatment is time-
Fig. 2. Light micrographs taken from retinas of rats 1 wk aft  er injection with N-methyl-N-nitrosourea (MNU) in diff  erent dosages. (A) A control 
retina of a rat injected with normal saline. (B) A retina of the rat injected with 40 mg/kg MNU. Th   e arrangement of photoreceptors in the outer 
nuclear layer (ONL) was slightly distorted and the thickness of the ONL was decreased. (C) A retina of a rat injected with 50 mg/kg MNU. 
Th   e changes in the ONL shown in A were progressed. In addition, distortion of the inner nuclear layer (INL) was observed. (D) A retina of a rat 
injected with 60 mg/kg MNU. Severe degenerative changes are found throughout all layers of the retina. OPL, outer plexiform layer; IPL, inner 
plexiform layer; GCL, ganglion cell layer. Scale bar=50 μm.Anat Cell Biol 2011;44:314-323 Eojin Jeong, et al 318
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dependent. Th   us, we examined changes in the function and 
histology over time in 50 mg/kg MNU-treated animals, which 
demonstrated signifi  cant changes in ERG responses, apparent 
decreases of photoreceptor layers and increases in GFAP 
expression. 
Fig. 4 shows MNU effects on ERG responses over time. 
Amplitudes of both a- and b-waves were reduced at 1 week 
by 37 and 29%, respectively, compared to those in control 
animals (a-wave, 24.2±3.8 μV vs. 38.6±4.3 μV; b-wave, 
68.4±11.1 μV vs. 95.9±6.0 μV) (Fig. 1). At 2 and 4 weeks, both 
ERG responses became progressively reduced by 47% and 
67% in a-waves and 45% and 75% in b-waves, respectively 
(a-wave, 20.5±5.2 μV and 12.8±5.8 μV; b-wave, 52.6±12.1 
μV and 33.4±6.5 μV), compared to those in control animals. 
Fig. 4C shows representative waveforms of ERG responses in 
control and MNU-treated eyes at diff  erent time points.
Histological aspect by H&E staining: As shown in Fig. 
2B, in retinal vertical sections taken from a retina 1 week 
after 50 mg/kg MNU injection, loss of 2-3 photoreceptor 
layers, disruption of the arrangement of the INL, and retinal 
edema were observed (Fig. 5B). Th   ese degenerative changes 
gradually progressed: the number of photoreceptor cell layers 
was 8-10 two weeks aft  er MNU injection (Fig. 5C) and was 
only 5-7 four weeks after. Thus, the final retinal thickness 
was about 56% of that of the control retina (Fig. 5D). Th  ese 
functional and histological fi  ndings suggest that degenerative 
changes in the retina treated with MNU are time-dependent.
Fig. 3. Confocal micrographs taken from the retinas processed for glial fi  brillary acidic protein (GFAP) immunoreactivities. Retinas were taken 
from rats injected with 40 mg/kg (B), 50 mg/kg (C), and 60 mg/kg (D) N-methyl-N-nitrosourea (MNU) aft  er 1 wk. (A) Th   e control rat retina. 
GFAP immunoreactivity is seen in end feet of Müller cells in the ganglion cell layer (GCL). (B-D) Th   e expression of GFAP in Müller cells gradually 
increased through the entire retina with increase of MNU dosage. ONL, outer nuclear layer; OPL, outer plexiform layer; INL, inner nuclear layer; 
IPL, inner plexiform layer. Scale bar=50 μm.Characterization of RD model induced by MNU
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Retinal injury evaluation by immunohistochemistry 
with anti-GFAP: In retinas after the 50 mg/kg MNU 
injection, GFAP expres  sion increased in a time-dependent 
manner (Fig. 6). Over time, the number of GFAP-labeled 
radial processes of Müller cells increased and the length of 
GFAP-immunoreactive processes was extended and thus, 
GFAP-immunoreactive Müller cell profiles were frequently 
observed in the INL (Fig. 6D). Th   ese results demonstrate that 
RD in the rat model with MNU injection is time-dependent. 
Discussion
Recently, there has been an increasing need for a well-
documented animal model for RD which can be used to study 
of RD as a heterogeneous group of human disease causing 
blindness. In the present study, we aimed to assess whether 
the rat model with MNU injection is of value as a RD animal 
model. We examined changes in function and histology in rat 
retinas ongoing RD evoked by MNU injection with diff  erent 
dosages and time points. Upon MNU injection of 40, 50 and 
60 mg/kg, ERG responses showed reduction in amplitudes 
of both a- and b-waves compared to control responses. At 
1 week, 2 weeks and 4 weeks after MNU injection (50 mg/
kg), amplitudes of both a- and b-waves also decreased. 
Consistent with these functional changes, histopathologic 
findings showed MNU dose- and time-dependent RD and 
expression of GFAP, a marker for retinal injury, increased. 
Th   is correlation among the results indicates that the rat RD 
model with MNU injection is of great value for the study of 
RD in human.
In humans, a representative RD disease is age-related 
ma  cular degeneration (AMD) which is the leading cause 
of blindness in the elderly in developed countries [20]. The 
cause of AMD is complex and many risk factors have been 
suggested, including age, family history (genetics), diet, 
smoking, and other environmental risk factors. The cellular 
components involved in the disease process are photoreceptor 
cells and retinal pigment epithelium (RPE), which gives 
metabolic support to the photoreceptor cells. In addition, the 
Bruch membrane, a complex of collagen and elastic layers 
interposed between the RPE and choroid where a capillary 
Fig. 4. Electroretinogram (ERG) 
recordings taken from eyes of the rats 
at different time points after 50 mg/
kg N-methyl-N-nitrosourea (MNU) 
injection. (A, B) Both a- and b-wave 
amplitudes reduced from 1 wk and 
significantly reduced at 4 wk. The 
results are presented as a normalized 
mean±SEM. *P<0.05 vs. control, 
†P<0.01 vs. control, 
‡P<0.05 vs. post-
MNU 1 wk. (C) Representative exam-
ples of ERG responses are shown to 
compare the changes of a- and b-wave 
in the control and MNU-treated eyes 
over time. Anat Cell Biol 2011;44:314-323 Eojin Jeong, et al 320
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bed provides the metabolic needs of the outer retina, is 
another key component affected [21]. To date, numerous 
inherited and chemically-induced animal models have been 
introduced. In inherited animal models, rd1 mouse mutated 
in the β-subunit of rod cGMP phosphodiesterase (Pdeb
rd1) 
[4, 6, 22] and rds mouse mutated in the retinal degeneration 
slow-peripherin (Prph2
Rd2) [5] have been well-documented. 
Both strains have shown similar pathologic events found in 
human AMD, affecting photoreceptors and RPE. However, 
inherited animal models have early onset of RD, while human 
AMD generally has a later onset. In addition, the development 
of drusen, subretinal deposits composed of a large number of 
different components including acute phase proteins, lipid, 
b-amyloid, and complement proteins, is rarely seen in animal 
models, even in aged genetically modifi  ed mice [23]. 
Chemically-induced animal models have also been used to 
gain insights into human AMD. Th   ere have been many studies 
to introduce several chemicals as potent retinal neurotoxins 
to induce RD. One of them, sodium iodate (NaIO3), is a 
stable retinotoxin that has been used as a RD animal model 
[17, 24]. However, two other study groups demonstrated a 
mismatch between visual function and histopathology of the 
retina [25, 26]. Additionally, in our preliminary test, NaIO3 
was not likely to reduce ERG responses significantly and or 
show apparent histopathologic findings (data not shown). 
However, the present study clearly shows that MNU reliably 
and reproducibly can cause RD. We also demonstrated that 
RD in this model shows correlation between visual function 
and histopathology of the retina, and MNU dose- and time-
dependency.
MNU used in this study has been widely used to develop 
a RD animal model for the evaluation of the effects of new 
therapeutic agents since Smith et al. [27] reported that 
MNU provokes a progressive RD. However, research groups 
have made RD animal models with MNU in a wide range 
of dosage,s from 40 mg/kg to 60 mg/kg [9, 10, 13, 16], 
Fig. 5. Light micrographs taken from rat retinas 1 wk (B), 2 wk (C), and 4 wk (D) aft  er 50 mg/kg N-methyl-N-nitrosourea (MNU) injection. (A) 
Control retina. (B-D) Loss of retinal neurons, especially photoreceptors in the outer nuclear layer (ONL), by MNU occurred in time-dependent 
manner. Th   e arrangements of retinal neurons in the ONL and the inner nuclear layer (INL) were progressively distorted and the retinal thickness 
decreased over time. OPL, outer plexiform layer; IPL, inner plexiform layer; GCL, ganglion cell layer. Scale bar=50 μm.Characterization of RD model induced by MNU
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indicating the absence of established protocol for MNU 
treat  ment. Most studies have focused on the investigation 
of whether short-term supplementation of certain agents 
can overcome more severe retinal damage caused by higher 
dose of MNU (>60 mg/kg) [13, 16, 28, 29]. To evaluate 
the effects of new therapeutic agents before clinical trials, 
long-term administration is prerequisite for toxicity tests. 
Th   us, we focused on the long-term progress RD induced by 
appropriate doses of MNU in an animal model. We found 
that RD induced by MNU is dose-dependent. However, 
admi  ni  stration of 40 mg/kg MNU did not show a signifi  cant 
reduction in ERG responses 1 week after MNU injection. 
Both 50 mg/kg and 60 mg/kg MNU injections showed signi-
ficant decreases in ERG responses. In the case of 60 mg/kg 
MNU injection, severe RD occurred and only about half of 
photoreceptor cells remained 1 week after MNU injection. 
Thus, we concluded that a dose of 50 mg/kg is appropriate 
for long-term observation in a RD animal model with MNU 
injection. Our conclusion was corroborated by the findings 
that functional and histological fi  ndings showed time-depen-
dent RD to 4 weeks when 50 mg/kg MNU was applied.
ERG represents the total eff  ects of various retinal neurons, 
pigment epithelium, and Müller cells [30, 31]. In flash of 
light stimulation, a- and b-waves are most often observed. 
Th   e a-wave is a negative component and refl  ects function of 
photoreceptors. Th   e b-wave is a corneal positive component 
and refl  ects ON bipolar cells and Müller cells. Because MNU 
induces selective photoreceptor cell death, we expected a 
Fig. 6. Confocal micrographs taken from retinas processed for glial fi  brillary acidic protein (GFAP) immunoreactivities. Th   e retinas were taken 
from the rats 1 wk (B), 2 wk (C), and 4 wk (D) aft  er 50 mg/kg N-methyl-N-nitrosourea (MNU) injection. (A) Control retina. (B-D) Th  e  GFAP 
immunoreativity was found mainly in Müller cell end feet in the ganglion cell layer (GCL) 1 wk aft  er MNU injection. Th   e expression of GFAP 
in Müller cells gradually increased through the entire retina over time. ONL, outer nuclear layer; OPL, outer plexiform layer; INL, inner nuclear 
layer; IPL, inner plexiform layer. Scale bar=50 μm.Anat Cell Biol 2011;44:314-323 Eojin Jeong, et al 322
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marked reduction in a-waves and a relatively small reduction 
in b-waves. However, similar reductions in both a- and 
b-waves were detected. These findings may be due to the 
relatively late observation time points. That is, we observed 
dose- and time-dependent effects of MNU 1 week after 
injection and afterwards. Based on previous reports that 
photoreceptor degeneration has been observed 24 hours aft  er 
MNU injection [9, 10, 14], our ERG results showing similar 
reductions in both a- and b-waves indicate that bipolar cells 
might be suff  ering secondary degeneration at the time points 
when we examined in the RD model used in this study. 
To evaluate the degree of retinal injury according to MNU 
injection in different doses, we observed GFAP expression 
by immunohistochemistry. GFAP is a reliable marker for 
profiling neurotoxicity [18, 19]. As expected, GFAP expres-
sion correlated with the degree of RD that is MNU dose- and 
time-dependent. These results indicate that GFAP is a good 
marker for the evaluation of RD.
In conclusion, a RD rat model with MNU injection shows 
RD in dose- and time-dependent manners. In this study, an 
application of 50 mg/kg MNU may be the best protocol for 
studying RD progression, mechanisms, and evaluation of 
long-term eff  ects of new therapeutic agents.
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